Lumexa Imaging Holdings, Inc.
LMRIHealthcareNASDAQMedical Devices · Last scanned Oct 26, 2026
Scan Results
Daily timeframeLumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The $1.12B market capitalization puts LMRI squarely in small-cap range for its industry. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services.
Market Cap
$1.12B
Beta
—
P/E (TTM)
—
P/E (Fwd)
13.10
EPS (TTM)
$-0.37
EPS (Fwd)
$0.89
ROE
—
ROA
—
Cash
$69.7M
Total Debt
$975.4M
Free CF
—
52W Change
-37.0%
Annual Financials
Cash vs Debt
Where LMRI stands vs its 150-day and 200-day moving averages
As of the October 9, 2026 close, LMRI finished 1.15% below its 150-day moving average ($10.45) and 11.02% below its 200-day moving average ($11.61). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is LMRI overbought or oversold?
At the October 9, 2026 close, LMRI's RSI(14) was 37.4, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $69.7M in cash, though total debt stands at $975.4M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Revenue has been relatively flat, moving from $935.9M (2023) to $1.02B (2025).
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Lumexa Imaging Holdings, Inc. and its sector.